市場調查報告書
商品編碼
1418519
單細胞基因組定序市場報告:2030 年趨勢、預測與競爭分析Single-Cell Genome Sequencing Market Report: Trends, Forecast and Competitive Analysis to 2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
單細胞基因組定序趨勢與預測
預計 2024 年至 2030 年,全球單細胞基因組定序市場將以 14.6% 的複合年成長率成長。該市場的主要促進因素包括癌症、糖尿病和關節炎等慢性疾病的盛行率不斷上升、先進技術和現代合作研究以及老年人口的增加。全球單細胞基因組定序市場的未來看起來充滿希望,循環細胞、細胞分化/重編程、基因組變異和亞群表徵市場存在機會。
單細胞基因組定序市場洞察
Lucintel 預計,由於採用尖端設備和解決方案,設備在預測期內仍將是最大的細分市場。
由於循環性腫瘤細胞的使用不斷增加,循環細胞仍然是市場中最大的部分。
由於癌症和其他慢性病盛行率不斷上升,北美在預測期內可能仍然是最大的地區。
Q1.市場成長預測如何?
A1. 2024年至2030年,全球單細胞基因組定序市場預計將以14.6%的複合年成長率成長。
Q2.影響市場成長的主要促進因素有哪些?
A2. 這個市場的主要促進因素是癌症、糖尿病和關節炎等慢性疾病的盛行率不斷上升、先進技術和現代協作研究以及老年人口數量的增加。
Q3.市場的主要細分市場有哪些?
A3. 單細胞基因組定序市場的未來看起來充滿希望,在循環細胞、細胞分化/重編程、基因組變異和亞群表徵市場方面存在著機會。
Q4.市場上主要企業有哪些?
A4.主要的單細胞基因組定序公司如下。
Q5.未來最大的細分市場是什麼?
A5.Lucintel 預計,由於採用尖端設備和解決方案,設備在預測期內仍將是其最大的細分市場。
Q6. 未來五年預計哪個地區將成為最大的市場?
A6. 由於癌症和其他慢性病盛行率不斷上升,預計北美在預測期內仍將是最大的地區。
Q7. 可以客製化報告嗎?
A7. 是的,Lucintel 提供 10% 的客製化服務,無需額外費用。
Single-Cell Genome Sequencing Trends and Forecast
The future of the global single-cell genome sequencing market looks promising with opportunities in the circulating cells, cell differentiation/reprogramming, genomic variation, and subpopulation characterization markets. The global single-cell genome sequencing market is expected to grow with a CAGR of 14.6% from 2024 to 2030. The major drivers for this market are chronic illnesses including cancer, diabetes, and arthritis are becoming more common, advanced technology and latest collaborations, and growing number of elderly people.
A more than 150-page report is developed to help in your business decisions.
Single-Cell Genome Sequencing by Segment
The study includes a forecast for the global single-cell genome sequencing by product type, workflow, application, end use, and region.
List of Single-Cell Genome Sequencing Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies single-cell genome sequencing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the single-cell genome sequencing companies profiled in this report include-
Single-Cell Genome Sequencing Market Insights
Lucintel forecasts that instruments will remain the largest segment over the forecast period due to embracing of cutting-edge instruments and solutions.
Within this market, circulating cells will remain the largest segment due to growing utilization of circulating tumor cells.
North America will remain the largest region over the forecast period due to rising prevalence of cancer and other chronic ailments.
Features of the Global Single-Cell Genome Sequencing Market
Market Size Estimates: Single-cell genome sequencing market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Single-cell genome sequencing market size by various segments, such as by product type, workflow, application, end use, and region in terms of value ($B).
Regional Analysis: Single-cell genome sequencing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product type, workflow, application, end use, and regions for the single-cell genome sequencing market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the single-cell genome sequencing market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the growth forecast for single-cell genome sequencing market?
Answer: The global single-cell genome sequencing market is expected to grow with a CAGR of 14.6% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the single-cell genome sequencing market?
Answer: The major drivers for this market are chronic illnesses including cancer, diabetes, and arthritis are becoming more common, advanced technology and latest collaborations, and growing number of elderly people.
Q3. What are the major segments for single-cell genome sequencing market?
Answer: The future of the single-cell genome sequencing market looks promising with opportunities in the circulating cells, cell differentiation/reprogramming, genomic variation, and subpopulation characterization markets.
Q4. Who are the key single-cell genome sequencing market companies?
Answer: Some of the key single-cell genome sequencing companies are as follows.
Q5. Which single-cell genome sequencing market segment will be the largest in future?
Answer: Lucintel forecasts that instruments will remain the largest segment over the forecast period due to embracing of cutting-edge instruments and solutions.
Q6. In single-cell genome sequencing market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to rising prevalence of cancer and other chronic ailments.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.